Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study

Published:2015 Issue:12 Volume:38 Page:1850-1855
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kajizono Makoto¹,Sada Hikaru¹,Sugiura Yuhko²,Soga Yoshihiko³,Kitamura Yoshihisa¹,Matsuoka Junji⁴,Sendo Toshiaki¹

Affiliation:

1. Department of Pharmacy, Okayama University Hospital

2. Division of Dental Hygienist, Okayama University Hospital

3. Division of Hospital Dentistry, Central Clinical Department, Okayama University Hospital

4. Department of Palliative and Supportive Care, Okayama University Hospital

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/38/12/38_b15-00385/_pdf

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Denosumab-Induced Maxillary Osteonecrosis: A Case Study on Long-Term Complications in Multiple Myeloma Treatment;Ear, Nose & Throat Journal;2024-06-16

2. Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-05

3. Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects;Archives of Oral Biology;2023-11

4. A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab;Cancer Medicine;2023-08-09

5. The Pathophysiology, Identification and Management of Fracture Risk, Sublesional Osteoporosis and Fracture among Adults with Spinal Cord Injury;Journal of Personalized Medicine;2023-06-08